Literature DB >> 21816707

Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Teresa S Miceli1, Kathleen Colson, Beth M Faiman, Kena Miller, Joseph D Tariman.   

Abstract

About 90% of individuals with multiple myeloma will develop osteolytic bone lesions from increased osteoclastic and decreased osteoblastic activity. Severe morbidities from pathologic fractures and other skeletal events can lead to poor circulation, blood clots, muscle wasting, compromised performance status, and overall poor survival. Supportive care targeting bone disease is an essential adjunct to antimyeloma therapy. In addition, the maintenance of bone health in patients with multiple myeloma can significantly improve quality of life. Oncology nurses and other healthcare providers play a central role in the management of bone disease and maintenance throughout the course of treatment. Safe administration of bisphosphonates, promotion of exercise, maintenance of adequate nutrition, vitamin and mineral supplementation, scheduled radiographic examinations, and monitoring of bone complications are among the important functions that oncology nurses and healthcare providers perform in clinical practice.

Entities:  

Mesh:

Year:  2011        PMID: 21816707      PMCID: PMC4189925          DOI: 10.1188/11.S1.CJON.9-23

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  67 in total

Review 1.  Radiotherapy in the management of plasma cell tumors.

Authors:  K Hu; J Yahalom
Journal:  Oncology (Williston Park)       Date:  2000-01       Impact factor: 2.990

2.  Solitary bone and extramedullary plasmacytoma.

Authors:  Donna M Weber
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

3.  Mobility and safety in the multiple myeloma survivor: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Sandra I Rome; Bonnie S Jenkins; Kathryn E Lilleby
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

Review 4.  The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.

Authors:  Joseph D Tariman; Stella Marie Estrella
Journal:  Oncol Nurs Forum       Date:  2005-11-03       Impact factor: 2.172

5.  International staging system for multiple myeloma.

Authors:  Philip R Greipp; Jesus San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Herve Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan J Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
Journal:  J Clin Oncol       Date:  2005-04-04       Impact factor: 44.544

6.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

7.  Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.

Authors:  I Breitkreutz; M S Raab; S Vallet; T Hideshima; N Raje; C Mitsiades; D Chauhan; Y Okawa; N C Munshi; P G Richardson; K C Anderson
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

8.  The short-term changes of bone mineral metabolism following bone marrow transplantation.

Authors:  M I Kang; W Y Lee; K W Oh; J H Han; K H Song; B Y Cha; K W Lee; H Y Son; S K Kang; C C Kim
Journal:  Bone       Date:  2000-03       Impact factor: 4.398

9.  Advances in supportive care of patients with cancer and bone metastases: nursing implications of zoledronic acid.

Authors:  Cathy Maxwell; Regina Swift; Melissa Goode; Lois Doane; Miriam Rogers
Journal:  Clin J Oncol Nurs       Date:  2003 Jul-Aug       Impact factor: 1.027

10.  The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study.

Authors:  Won Young Lee; Moo Il Kang; Ki Hyun Baek; Eun Sook Oh; Ki Won Oh; Kwang Woo Lee; Sun Woo Kim; Choon Choo Kim
Journal:  J Korean Med Sci       Date:  2002-12       Impact factor: 2.153

View more
  3 in total

1.  Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

Authors:  Beth M Faiman; Patricia Mangan; Jacy Spong; Joseph D Tariman
Journal:  Clin J Oncol Nurs       Date:  2011-08       Impact factor: 1.027

Review 2.  The Biological Activities of Oleocanthal from a Molecular Perspective.

Authors:  Kok-Lun Pang; Kok-Yong Chin
Journal:  Nutrients       Date:  2018-05-06       Impact factor: 5.717

3.  Current practice patterns of osteoporosis treatment in cancer patients and effects of therapeutic interventions in a tertiary center.

Authors:  Nasa Fujihara; Yuki Fujihara; Shunsuke Hamada; Masahiro Yoshida; Satoshi Tsukushi
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.